Subclinical effects of botulinum toxin A and microwave thermolysis for axillary hyperhidrosis: A descriptive study with line-field confocal optical coherence tomography and histology.
Gabriela Lladó GroveKevin JacobsenNina Loeth MaartenssonMerete HaedersdalPublished in: Experimental dermatology (2024)
Botulinum toxin A (BTX) and microwave thermolysis (MWT) are standard axillary hyperhidrosis treatments, but comparison of their subclinical effects is lacking. Line-field confocal optical coherence tomography (LC-OCT) is a promising non-invasive imaging tool for visualizing tissue-interactions. This study aimed to describe subclinical effects of BTX and MWT for axillary hyperhidrosis with LC-OCT-imaging compared to histology. This study derived from an intra-individual, randomized, controlled trial, treating axillary hyperhidrosis with BTX versus MWT. Subclinical effects based on LC-OCT images from baseline and 6-month follow-up (n = 8 patients) were evaluated and compared to corresponding histological samples. At baseline, LC-OCT visualized eccrine pores at the skin surface and ducts in the upper dermis (500 μm), but not deeper-lying sweat glands. Histology identified entire sweat glands. Six months post-treatment, LC-OCT revealed no detectable morphology changes in any BTX-treated axillae (100%), while recognizing obstructed eccrine pores and atrophy of eccrine ducts in most MWT-treated axillae (75%). Histology corroborated LC-OCT findings, while also showing substantial changes to entire sweat glands. LC-OCT enabled visualization of subclinical alterations of superficial eccrine ducts after MWT and unchanged morphology after BTX. LC-OCT is a promising tool for non-invasive assessment of treatment-specific tissue-interactions that can be complementary to histology.
Keyphrases
- sentinel lymph node
- optical coherence tomography
- lymph node
- early stage
- neoadjuvant chemotherapy
- diabetic retinopathy
- simultaneous determination
- botulinum toxin
- randomized controlled trial
- optic nerve
- mass spectrometry
- liquid chromatography
- newly diagnosed
- end stage renal disease
- chronic kidney disease
- tandem mass spectrometry
- ejection fraction
- combination therapy
- prognostic factors
- convolutional neural network
- peritoneal dialysis
- gas chromatography